Abstract

H1 Trade marks – Pharmaceuticals – Parallel imports – Re-branding – Trade mark use – Trade mark proprietor not the manufacturer of the imported products – Use of disclaimer – Whether prevention of imports a disguised restriction on competition – The BMS conditions – Whether consent to placing on the market a precondition to applicability of pleaded defence – Whether consent given – Whether re-branding necessary to gain access to relevant market

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call